Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Innate Inflammatory Response

1-methyl-4-phenylpyridinium has been researched along with Innate Inflammatory Response in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (21.05)29.6817
2010's7 (36.84)24.3611
2020's8 (42.11)2.80

Authors

AuthorsStudies
Sun, X; Tao, H; Wu, X; Yao, S; Zhang, C1
Bae, JE; Cho, DH; Jo, DS; Jung, YK; Kim, JB; Kim, P; Kim, SH; Kim, YH; Lee, HJ; Lee, HS; Lee, WH; Park, NY; Ryoo, ZY; Ryu, HY; Son, M1
Fu, S; Gao, X; He, D; He, Y; Li, J; Li, Z; Liu, D; Liu, Y; Wang, H; Ye, B1
Huang, YH; Lin, TK; Yang, YL1
Hu, Q; Qi, W; Xiong, X; Zeng, D1
Chang, KH; Chen, CM; Chen, YC; Chiu, YJ; Lee-Chen, GJ; Lin, CH; Lin, CY; Lo, YS; Wu, YR; Yang, PN; Yao, CF1
Amiry-Moghaddam, M; Ottersen, OP; Prydz, A; Skare, Ø; Skauli, N; Stahl, K; Zahl, S1
Tian, J; Wang, H; Xu, F; Xu, H1
Chen, L; Chen, Z; Gao, X; Xu, J; Yang, C1
Choi, MS; Jeon, MT; Jung, UJ; Kim, SR1
Lai, TH; Lin, YL; Shiao, YJ; Tsay, HJ; Tzeng, TT1
Chen, Z; Liao, J; Liu, X; Wang, Q; Wang, R; Wang, Y; Weng, R; Xia, Y; Zhou, P; Zou, J1
Borrajo, A; Diaz-Ruiz, C; Garrido-Gil, P; Labandeira-Garcia, JL; Rodriguez-Perez, AI1
Brundin, P; Colca, JR; Escobar Galvis, ML; George, S; Ghosh, A; Hildebrandt, EN; Kordower, JH; Machiela, E; Madaj, Z; McDonald, WG; Schulz, E; Steiner, JA; Tyson, T; Van Raamsdonk, JM1
El-Benna, J; Flood, PM; Hong, JS; Hu, X; Qian, L; Wei, SJ; Wilson, B; Xu, Z; Zhang, D1
Bournival, J; Martinoli, MG; Plouffe, M; Provencher, C; Renaud, J1
An, L; Hong, JS; Li, G; Liu, B; Liu, Y; Qin, L; Zhang, W1
Hong, JS; Liu, B; Wang, T; Wilson, B; Zhang, W1
Goralski, KB; Renton, KW1

Other Studies

19 other study(ies) available for 1-methyl-4-phenylpyridinium and Innate Inflammatory Response

ArticleYear
LINC00943 acts as miR-338-3p sponge to promote MPP
    Brain research, 2022, 05-01, Volume: 1782

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Line, Tumor; Inflammation; Mice; MicroRNAs; Parkinson Disease; RNA, Long Noncoding; Sp1 Transcription Factor

2022
Carnitine Protects against MPP
    Cells, 2022, 09-01, Volume: 11, Issue:17

    Topics: 1-Methyl-4-phenylpyridinium; Acetylcarnitine; Apoptosis; Carnitine; Cell Line, Tumor; Dopaminergic Neurons; Humans; Inflammation; Neuroblastoma; Neurotoxicity Syndromes

2022
Isoalantolactone (IAL) Regulates Neuro-Inflammation and Neuronal Apoptosis to Curb Pathology of Parkinson's Disease.
    Cells, 2022, 09-19, Volume: 11, Issue:18

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Inflammation; Inflammation Mediators; Iodides; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Proto-Oncogene Proteins c-akt; Pyrrolidines; Sesquiterpenes

2022
MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS.
    European journal of pharmacology, 2022, Nov-05, Volume: 934

    Topics: 1-Methyl-4-phenylpyridinium; 3' Untranslated Regions; Antiviral Agents; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Humans; Inflammation; Interleukin-6; MicroRNAs; Neuroblastoma; Parkinson Disease; Poly(ADP-ribose) Polymerase Inhibitors; Reactive Oxygen Species; Superoxide Dismutase

2022
Knockdown of SEMA7A alleviates MPP
    Immunity, inflammation and disease, 2023, Volume: 11, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Antigens, CD; Apoptosis; Inflammation; Mice; Microglia; Mitogen-Activated Protein Kinases; PPAR gamma; Semaphorins

2023
Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson's Disease.
    International journal of molecular sciences, 2023, Jan-30, Volume: 24, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Humans; Inflammation; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; Neurotoxins; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Parkinson Disease; Tumor Necrosis Factor-alpha

2023
Pro-Inflammatory Role of AQP4 in Mice Subjected to Intrastriatal Injections of the Parkinsonogenic Toxin MPP.
    Cells, 2020, 11-05, Volume: 9, Issue:11

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Aquaporin 4; Astrocytes; Dopaminergic Neurons; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Injections; Male; Mesencephalon; Mice, Inbred C57BL; Neuroglia; Parkinson Disease; RNA, Messenger; Substantia Nigra

2020
Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Neurochemical research, 2021, Volume: 46, Issue:8

    Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Knockdown Techniques; Humans; Inflammation; Janus Kinase 2; MicroRNAs; Oxidative Stress; Parkinson Disease; Receptor, Interferon alpha-beta; RNA, Long Noncoding; Signal Transduction; STAT1 Transcription Factor; Up-Regulation

2021
Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Jun-02, Volume: 23

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Disease Models, Animal; Docosahexaenoic Acids; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Inflammation; Interleukin-6; MAP Kinase Kinase 4; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; PC12 Cells; Phosphorylation; Rats; Tumor Necrosis Factor-alpha; Up-Regulation

2017
Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
    Journal of medicinal food, 2014, Volume: 17, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-1beta; Microglia; Nerve Degeneration; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Substantia Nigra; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase

2014
Lithospermic acid attenuates 1-methyl-4-phenylpyridine-induced neurotoxicity by blocking neuronal apoptotic and neuroinflammatory pathways.
    Journal of biomedical science, 2015, May-28, Volume: 22

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Inflammatory Agents; Apoptosis; Benzofurans; Cell Line; Depsides; Inflammation; Male; Mice; Mice, Inbred ICR; Neurogenesis; Neurons

2015
TLR4 Signaling in MPP⁺-Induced Activation of BV-2 Cells.
    Neural plasticity, 2016, Volume: 2016

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Line; Cell Survival; In Vitro Techniques; Inflammation; Interleukin-1beta; Mice; Microglia; NF-kappa B; Nitric Oxide Synthase Type II; Parkinson Disease; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2016
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: 1-Methyl-4-phenylpyridinium; Age Factors; Aging; Angiotensin II; Animals; Apoptosis; Cells, Cultured; Dopaminergic Neurons; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Inflammation; Injections, Intraventricular; Insulin-Like Growth Factor I; Microglia; Neurodegenerative Diseases; Oxidative Stress; Primary Cell Culture; Rats; Receptor, Angiotensin, Type 1; Receptor, IGF Type 1; Renin-Angiotensin System; Substantia Nigra

2016
Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
    Science translational medicine, 2016, 12-07, Volume: 8, Issue:368

    Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Autophagy; Behavior, Animal; Brain; Caenorhabditis elegans; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Heterozygote; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neurodegenerative Diseases; Neurons; Oxygen Consumption; Parkinson Disease; Pyridines; Pyruvic Acid; Signal Transduction; Substantia Nigra; Thiazolidinediones

2016
Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Jul-01, Volume: 181, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Membrane; Cytoprotection; Cytosol; Dopamine; Inflammation; Lipopolysaccharides; Membrane Glycoproteins; Mice; Mice, Knockout; Microglia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 2; NADPH Oxidases; Phosphoserine; Protein Subunits; Protein Transport; Rats; Reactive Oxygen Species; Tissue Culture Techniques; Transforming Growth Factor beta1

2008
Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system.
    Oxidative medicine and cellular longevity, 2012, Volume: 2012

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Coculture Techniques; Cytokines; Cytoprotection; Dioxoles; Dopaminergic Neurons; Gene Expression Regulation; Inflammation; Kinetics; Lignans; Mice; Microglia; Mitochondria; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; PC12 Cells; Quercetin; Rats; RNA, Messenger; Superoxides

2012
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Amyloid beta-Peptides; Animals; Cells, Cultured; Dextromethorphan; Drug Interactions; Inflammation; Lipopolysaccharides; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Receptors, Dopamine; Superoxides; Xanthine; Xanthine Oxidase

2003
Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Cyclooxygenase 2; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Inflammation; Isoenzymes; Lipopolysaccharides; Male; Mesencephalon; Microglia; Nerve Degeneration; Neuroglia; Neurons; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344

2004
Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats.
    Toxicology and applied pharmacology, 2004, May-01, Volume: 196, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain; Cytochrome P-450 Enzyme System; Dopamine Agents; Inflammation; Kidney; Lipopolysaccharides; Liver; Lung; Male; Rats; Rats, Sprague-Dawley

2004